TY - JOUR
T1 - Prognostic markers for diet-induced weight loss in obese women
AU - Astrup, Arne
AU - Buemann, B.
AU - Gluud, C.
AU - Bennett, P.
AU - Tjur, T.
AU - Christensen, N.
PY - 1995
Y1 - 1995
N2 - Objective: To identify prognostic metabolic and hormonal markers for long-term weight loss outcome in obese women. Design: Dietary intervention consisting of 36 weeks treatment by a 4.2 MJ/d low-fat high carbohydrate diet, and follow-up 2 1/2 years after termination of treatment. Setting: Outpatient clinic in Copenhagen. Subjects: Forty consecutive female obese patients aged 15 to 62 years. Main outcome measure: Weight loss. Results: The maximum weight loss (mean 16.2 kg, 95% CI 14.2-18.2) was positively associated to pre-treatment 24-h energy expenditure (P < 0.01), fat oxidation (%) (P < 0.02), plasma dihydrotestosterone (DHT) (P < 0.01), and to postprandial noradrenaline concentration (P < 0.04). Together these factors could explain 41% of the variation in maximum weight loss. Only 24-h EE and DHT had predictive power on weight loss after 36 weeks. Weight losses in upper and lower tertiles of DHT concentrations were 17.7 kg (14.1-21.4) and 9.8 kg (6.2-13.3) (P < 0.02). The adjusted relative risk of losing < 10 kg in the upper compared to the lower DHT tertile was 12% (4-32%). At 2 1/2 y follow-up 21 patients had maintained some of the weight loss (54%), while 14 patients had maintained > 5 kg weight loss (36%). High levels of pre-treatment DHT were also associated with better weight loss at 2 1/2 y follow-up. Conclusion: The study suggests that in particular DHT, but also 24-h EE, fat oxidation, and plasma noradrenaline, may be prognostic markers for weight loss outcome in obese women.
AB - Objective: To identify prognostic metabolic and hormonal markers for long-term weight loss outcome in obese women. Design: Dietary intervention consisting of 36 weeks treatment by a 4.2 MJ/d low-fat high carbohydrate diet, and follow-up 2 1/2 years after termination of treatment. Setting: Outpatient clinic in Copenhagen. Subjects: Forty consecutive female obese patients aged 15 to 62 years. Main outcome measure: Weight loss. Results: The maximum weight loss (mean 16.2 kg, 95% CI 14.2-18.2) was positively associated to pre-treatment 24-h energy expenditure (P < 0.01), fat oxidation (%) (P < 0.02), plasma dihydrotestosterone (DHT) (P < 0.01), and to postprandial noradrenaline concentration (P < 0.04). Together these factors could explain 41% of the variation in maximum weight loss. Only 24-h EE and DHT had predictive power on weight loss after 36 weeks. Weight losses in upper and lower tertiles of DHT concentrations were 17.7 kg (14.1-21.4) and 9.8 kg (6.2-13.3) (P < 0.02). The adjusted relative risk of losing < 10 kg in the upper compared to the lower DHT tertile was 12% (4-32%). At 2 1/2 y follow-up 21 patients had maintained some of the weight loss (54%), while 14 patients had maintained > 5 kg weight loss (36%). High levels of pre-treatment DHT were also associated with better weight loss at 2 1/2 y follow-up. Conclusion: The study suggests that in particular DHT, but also 24-h EE, fat oxidation, and plasma noradrenaline, may be prognostic markers for weight loss outcome in obese women.
KW - Androgens
KW - Catecholamines
KW - Energy expenditure
KW - Prediction of weight loss
KW - Weight maintenance
UR - http://www.scopus.com/inward/record.url?scp=0028914905&partnerID=8YFLogxK
M3 - Journal article
C2 - 7627252
AN - SCOPUS:0028914905
VL - 19
SP - 275
EP - 278
JO - International Journal of Obesity
JF - International Journal of Obesity
SN - 0307-0565
IS - 4
ER -